Mandate and instrument identity
Record the legal instrument, issuer, identifier and permitted investment mandate.
DN Markets / Build a reviewable decision
A practical diligence workspace for investment committees, treasury teams and analysts. Make unresolved questions portable.
Research pathways
DN Institutional Worksheet
For investment committees, treasury teams and research analysts. Mark your own workflow; this page does not validate your documents. Selections stay in this tab and reset on reload.
Record the legal instrument, issuer, identifier and permitted investment mandate.
Obtain governing terms for ownership, distributions, redemption and insolvency claims.
Document entity-specific access and the applicable legal review. An IP location is not an eligibility decision.
Identify custodians, omnibus arrangements, segregation and independent assurance scope.
Record executable size, spreads, redemption windows, suspension rights and settlement path.
Record source, timestamp, currency, units, market session and stale-price handling.
Document permissions, recovery, reconciliation, incident escalation and counterparty dependencies.
Confirm redistribution licences, source provenance, review owner and expiry or update triggers.
0 of 8 areas marked as documented by you. This is a completeness count, not a risk score or approval.
Evidence & methodology
A selective research directory of benchmark designs, product structures and AI value-chain exposure. Inclusion is editorial coverage, not an investment ranking, endorsement or eligibility determination. No live prices, constituent weights, performance series or execution observations are collected. AI categories and diligence questions are DN interpretations of linked primary sources. Review dates describe our source review, not provider release dates. Individual token records identify issuer and reference asset separately. Network labels are documentary evidence, not verified contracts or trading routes; unverified fields remain explicit.
Reviewed by Decentralised News editorial research. Review due 28 October 2026. After that date, treat these records as historical pending a new published review.
No live prices, investment returns, verified trading availability, eligibility decisions, regulatory approvals or audited institutional suitability. Source access does not grant a market-data redistribution licence.
Tools compute locally. No entered prices, weights or worksheet selections are sent by these tools. Existing site analytics and third-party site services remain subject to DN’s privacy policy.
Download the dated research dataset (JSON)Third-party source material remains the property of its owners. This download contains DN summaries and source links, not licensed market feeds.
Connected to DN
Educational research, not investment, legal or tax advice. DN may earn commissions from commercial links elsewhere. This workspace has no paid placement, trading CTA or compensation-based ranking.